|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 89, Issue 3 331-342, Copyright © 1988 by Company of Biologists
JOURNAL ARTICLES |
ME Stearns and KD Tew
Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, PA 19111.
We have investigated the ability of estramustine to bind to rat brain microtubule-associated proteins (MAPs) and purified MAP-2 in vitro. [3H]estramustine's relative affinity for tubulin and MAPs was assessed by gel filtration chromatography, immunoprecipitation and binding assays. Scatchard analysis demonstrated a specific affinity of the drug for MAP-2. Calculations from kinetic parameters and non-linear regression analysis gave a Kd of 15 microM, and a Bmax of 3.4 x 10(-7)M ml-1. Extrapolation of this value suggested that each MAP-2 molecule binds approximately 20 molecules of estramustine. Microtubule assembly studies and SDS-polyacrylamide gel electrophoresis revealed that at 20-60 microM levels, estramustine inhibited the association of MAPs with taxol microtubules. Turbidity (A350) studies further demonstrated that 20-60 microM-estramustine inhibited MAP-2-driven tubulin assembly and produced microtubule disassembly. Electron-microscopic studies confirmed the centrifugation and turbidity results. The data demonstrated that estramustine can bind MAPs and MAP-2 specifically, thereby inhibiting microtubule assembly.
This article has been cited by other articles:
|
|
 |
|
  R. Mohan and D. Panda Kinetic Stabilization of Microtubule Dynamics by Estramustine Is Associated with Tubulin Acetylation, Spindle Abnormalities, and Mitotic Arrest Cancer Res., August 1, 2008; 68(15): 6181 - 6189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Bonham, A. Galkin, B. Montgomery, W. L. Stahl, D. Agus, and P. S. Nelson Effects of the Herbal Extract PC-SPES on Microtubule Dynamics and Paclitaxel-Mediated Prostate Tumor Growth Inhibition J Natl Cancer Inst, November 6, 2002; 94(21): 1641 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bonham, H. Arnold, B. Montgomery, and P. S. Nelson Molecular Effects of the Herbal Compound PC-SPES: Identification of Activity Pathways in Prostate Carcinoma Cancer Res., July 15, 2002; 62(14): 3920 - 3924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Sweeney, F. J. Monaco, S.-H. Jung, M. J. Wasielewski, J. Picus, R. H. Ansari, W. M. Dugan, and L. H. Einhorn A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer Ann. Onc., March 1, 2002; 13(3): 435 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hudes, N. Haas, G. Yeslow, T. Gillon, P. O. Gunnarsson, M. Ellman, O. Nordle, B. Eriksson, L. Miller, L. Cisar, et al. Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate J. Clin. Oncol., February 15, 2002; 20(4): 1115 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Dixon, K. B. Knopf, and W. D. Figg The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents Pharmacol. Rev., March 1, 2001; 53(1): 73 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Panda, H. P. Miller, K. Islam, and L. Wilson Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: A possible mechanistic basis for its antitumor action PNAS, September 30, 1997; 94(20): 10560 - 10564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Nathan, D. L. Keefe, M. A. Weinstein, Zhaocong Chen, and F. Naftolin Estrogen Mustard Induces Cell Cycle Arrest of Human Epithelial Ovarian Cancer Cell Lines Reproductive Sciences, January 1, 1994; 1(1): 97 - 103. [Abstract] [PDF]
|
|
